NCT01771419

Brief Summary

Selective cannulation of common bile duct (CBD) by insertion of a guide-wire seems to be associated with fewer complications and post-ERCP (Endoscopic retrograde cholangiopancreatography) pancreatitis (PEP) rate than the conventional biliary tree access with cannulotome (CT-25 Cook Medical) with contrast injection even if results are conflicting. the aim of our study is to test a new guide-wire (loop-tip wire), with a loop in the tip, for the prevention of PEP and biliary tree access, in PEP high-risk patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

January 15, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 18, 2013

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 18, 2013

Status Verified

January 1, 2013

Enrollment Period

2.3 years

First QC Date

January 15, 2013

Last Update Submit

January 16, 2013

Conditions

Keywords

loop-tipERCPcannulation of CBD

Outcome Measures

Primary Outcomes (1)

  • post ERCP pancreatitis rate

    participants will be followed for the duration of hospital stay, an expected average of 2 weeks

    up to 4 weeks

Secondary Outcomes (1)

  • Number of attempts to obtain the cannulation of CBD and number of participants with adverse events as a measure of safety and tolerability

    up to 4 weeks

Study Arms (2)

loop-tip arm

EXPERIMENTAL

The cannulation of CBD will be obtained using the loop-tip wire (Cook Medical inc.)

Device: Loop-tip wire (Cook Medical) for the cannulation of the CBD

Control arm

ACTIVE COMPARATOR

The cannulation of CBD will be obtained with a Cook Medical sphincterotome CT-25 mm (tradictional technique)

Device: Cannulotome CT-25mm Cook Medical

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • high-risk patients for post-ERCP pancreatitis

You may not qualify if:

  • age \< 18 years
  • allargy to the contrast medium
  • previous biliary or gastric surgery
  • neoplastic patients
  • previous biliary or pancreatic sphincterotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Paolo Hospital

Milan, Italy, 20142, Italy

RECRUITING

Related Publications (1)

  • Masci E, Mangiavillano B, Luigiano C, Bizzotto A, Limido E, Cantu P, Manes G, Viaggi P, Spinzi G, Radaelli F, Mariani A, Virgilio C, Alibrandi A, Testoni PA. Comparison between loop-tip guidewire-assisted and conventional endoscopic cannulation in high risk patients. Endosc Int Open. 2015 Oct;3(5):E464-70. doi: 10.1055/s-0034-1392879. Epub 2015 Sep 15.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 15, 2013

First Posted

January 18, 2013

Study Start

October 1, 2010

Primary Completion

February 1, 2013

Study Completion

January 1, 2014

Last Updated

January 18, 2013

Record last verified: 2013-01

Locations